USPTO serial 97806747
EMED WOMEN
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- XU, ELAINE YILIN
- Law office
- TMO LAW OFFICE 127
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EMED WOMEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas Y. Yee
Thomas Y. Yee Perkins Coie LLPP.O. Box 2608Seattle, WA 98111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection in the fields of reproductive medicine, women health; Diagnostic kit comprised of medical diagnostic reagents and assays that test for the presence of reproductive medical conditions, women's health conditions; medical diagnostic rapid test kits comprised of chemical reagents, solvents, swabs, vials, and containers for safely storing tests for analysis and use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants; diagnostic media for cultures for use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants for medical purposes; rapid test kits for medical purposes comprised of chemical reagents, solvents, swabs, vials and containers for safely storing tests for analysis and use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants | ABANDONED | — |
| 009 | Downloadable software and downloadable mobile applications for use in connection with detecting, screening, and monitoring the presence of diseases; downloadable software and downloadable mobile applications for use in connection with detecting, screening, and monitoring medical conditions in the fields of reproductive medicine, women health; downloadable educational software and downloadable educational mobile applications featuring instruction in the field of medical and health related training; downloadable software and downloadable mobile applications for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; none of the foregoing for use in emergency medicine and none of the foregoing for training medical professionals | ABANDONED | — |
| 036 | Financial administration of health reimbursement arrangements and programs; Reimbursement payment processing in the field of insurance claims; Providing healthcare administration, namely, providing insurance verification in the health industry and reimbursement payment processing services in the field of insurance claims; Insurance claims processing services, namely, submitting claims for preauthorization in the healthcare industry | ABANDONED | — |
| 038 | Audio teleconferencing; instant messaging services; network conferencing services; teleconferencing services; video conferencing services; video teleconferencing | ABANDONED | — |
| 042 | Providing on-line, non-downloadable internet-based software for use in detecting, screening and monitoring the presence of diseases; providing on-line, non-downloadable cloud-based software for use in detecting, screening and monitoring the presence of diseases; software as a service (SAAS) services featuring software for use in detecting, screening and monitoring the presence of diseases; platform as a service (PAAS) featuring computer software platform for detecting, screening, and monitoring the presence of diseases; Providing on-line, non-downloadable internet-based software for use in connection with detecting, screening, and monitoring medical conditions in the fields of reproductive medicine, women health; providing on-line, non-downloadable cloud-based software for use in connection with detecting, screening, and monitoring medical conditions in the fields of reproductive medicine, women health; software as a service (SAAS) services featuring software for use in connection with detecting, screening, and monitoring medical conditions in the fields of reproductive medicine, women health; platform as a service (PAAS) featuring computer software platforms for detecting, screening, and monitoring medical conditions in the fields of reproductive medicine, women health; providing on-line, non-downloadable internet-based software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; providing on-line, non-downloadable cloud-based software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; software as a service (SAAS) services featuring software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; platform as a service (PAAS) featuring computer software platform for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; providing temporary use of on-line non-downloadable mobile applications for use in connection with detecting, screening, and monitoring the presence of diseases; providing temporary use of on-line non-downloadable mobile applications for use in conducting medical and health related education and training; providing temporary use of on-line non-downloadable mobile applications for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; software as a service (SAAS) services featuring software for providing an online platform that enables video conferencing connectivity between proctors and users; software as a service (SAAS) services featuring software for live digital communications, namely, live video and audio conferencing with multiple simultaneous users, teleconferencing, and network conferencing; software as a service (SAAS) services featuring software for providing an online platform to enable workflow management of a proctored examination; software as a service (SAAS) services featuring software for providing an online platform to enable video conferencing connectivity between proctors and users to conduct a proctored test; platform as a service (PAAS) featuring computer software platforms for proctoring of exams; platform as a service (PAAS) featuring computer software platforms for providing online identity verification services and for creating identity verification reports; platform as a service (PAAS) featuring computer software platforms for providing process verification services for businesses and for creating process verification reports; providing temporary use of non-downloadable cloud based software as a service (SAAS) services, comprising AI-enabled proctoring to ensure integrity of remote assessments with real-time image, audio, and video proctoring, assessing functional, programming, technical and communication skills in real-time with video interviews, preventing cheating using AI, and conducting video interviews; software as a service (SAAS) services featuring software for secure exam proctoring and content protection, identification verification, and data analytics associated therewith; software as a service (SAAS) services featuring software for providing proctored examination testing, examination monitoring, and for reporting examination results to government agencies, insurers, employers, companies, and users; providing temporary use of on-line non-downloadable cloud-based computer software for autonomous online proctoring and identity verification; providing temporary use of online non-downloadable software for enabling video conferencing connectivity between proctors and users; software as a service (SAAS) services featuring software for providing an online platform that enables users to order diagnostic tests, to take diagnostic tests online with the guidance of a proctor, to view and access test results, and to order pharmaceuticals and prescriptions; software as a service (SAAS) services featuring software for providing an online platform that enables AI-based guidance through self-administered diagnostic tests; software as a service (SAAS) services featuring software for providing an online platform that enables users to access digital health results ; none of the foregoing for use in emergency medicine and none of the foregoing for training medical professionals | ABANDONED | — |
| 044 | Provision of remote medical services, namely, assessing patient eligibility for medication and prescribing medication; medical services in the field of women health | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EMED, LLC
- Other trademarks owned by EMED, LLC
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 036
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EMED WOMEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 10, 2024 | MAB5 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | — |
| Aug 10, 2024 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Aug 9, 2024 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Mar 5, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 20, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 4, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 4, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 4, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 4, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 4, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 3, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 3, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 31, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 10, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 10, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 13, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 25, 2023 | NWAP | NEW APPLICATION ENTERED | — |